Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

6.1K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Castleman's disease in the rheumatological practice.

Zeitschrift fur Rheumatologie·2024
Same author

Bessel's disease-the first report of an IgG4-related disorder.

Zeitschrift fur Rheumatologie·2024
Same author

[Castleman's disease in the rheumatological practice].

Zeitschrift fur Rheumatologie·2023
Same author

["Rheuma (be-)greifen"- A multimodal teaching concept to improve rheumatology education for medical students].

Zeitschrift fur Rheumatologie·2023
Same author

[Development of quality standards for patients with rheumatoid arthritis for use in Germany].

Zeitschrift fur Rheumatologie·2021
Same author

[80 milestones in rheumatology from 80 years- I. 1940-1960].

Zeitschrift fur Rheumatologie·2021
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Legal and societal aspects of doping in sport].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[The institutionalisation of infection prevention and control in Germany: challenges since the "Gründerzeit" : A retrospect of over 50 years of KRINKO].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

50.5K

[Not Available].

J Braun1, B Manger

  • 1Rheumazentrum Ruhrgebiet, Herne und Freie Universität, Berlin, Germany.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|April 15, 2014
PubMed
Summary
This summary is machine-generated.

Tumor necrosis factor-alpha (TNFα) antagonists are highly effective for treating ankylosing spondylitis (AS) and psoriatic arthritis (PsA). This breakthrough therapy offers significant relief for axial and peripheral symptoms in spondyloarthritis patients.

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

24.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

24.4K

Related Experiment Videos

Last Updated: May 1, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

50.5K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

24.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

24.4K

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Context:

  • Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are prevalent inflammatory rheumatic conditions within the spondyloarthritis (SpA) spectrum.
  • Limited therapeutic options historically constrained management of SpA.
  • Emerging research highlights the critical role of tumor necrosis factor-alpha (TNFα) in SpA pathogenesis.

Purpose:

  • To evaluate the efficacy of TNFα antagonists in treating AS and PsA.
  • To assess the impact of TNFα antagonists on both axial and peripheral symptoms of SpA.
  • To compare the effectiveness of TNFα antagonists in SpA versus rheumatoid arthritis (RA).

Summary:

  • Randomized controlled trials demonstrate significant efficacy of TNFα antagonists for AS and PsA.
  • Treatment with TNFα antagonists addresses both axial and peripheral disease manifestations effectively.
  • Evidence suggests TNFα antagonists may be more effective in SpA than in RA, comparable to corticosteroids in polymyalgia rheumatica.

Impact:

  • TNFα antagonists represent a major therapeutic advancement for rheumatic diseases, particularly SpA.
  • This treatment offers improved outcomes for patients with AS and PsA.
  • The availability of TNFα antagonists has transformed the management landscape for spondyloarthritis.